“I think she was going to be here.”
Yesterday President Biden gave a speech at a White House event.
In an attempt at a bipartisan shout-out to those on the House Hunger Caucus, the President said, “Jackie are you here? Where’s Jackie?”
If It Weren’t So Frightening, It’d Be Funny
It’s believed that he was referring to Indiana Congresswoman Jackie Walorski, who died in a car crash in August. In a statement on her death, the White House noted her work as co-chair of the caucus. Apparently, reports BRIGHT editors, Joe Biden’s delivered remarks were not updated.
To make matters worse, White House Press Secretary Karine Jean-Pierre said he was simply “acknowledging her incredible work,” claiming President Biden knew she was deceased.
Of course, he did.
Rationing an Alzheimer’s Drug
Taking credit for the modest decline in Medicare prices, President Biden also forgot to mention the reason, reports the WSJ: “(The Biden) Administration is rationing a novel Alzheimer’s drug,”
From President Biden
“This year, the American people won, and Big Pharma lost.”
The President also accused Republicans of seeking to gut entitlements as he flogged Medicare drug price controls that Democrats are using to pay for $369 billion in new climate spending. But Democrats are the party slashing Medicare via cost rationing, counters the WSJ.
From President Biden:
“This morning, we got more even good news about lowering costs. The Department of Health and Human Services announced that the premium for Part B will, in fact, decrease this [upcoming] year. … for years, that fee has gone up. Now, for the first time in more than a decade, it’s going to go down.”
Mr. Biden wants Americans to believe that drug price controls are reducing premiums, writes the WSJ. Here’s the deal:
(Biden’s) Administration increased Part B premiums by 14.5% this year and blamed the increase on expected high demand for Biogen’s Alzheimer’s drug Aduhelm, which the Food and Drug Administration approved last summer.
As a result, seniors by and large haven’t been able to take advantage of Aduhelm and have therefore overpaid for their Medicare Part B premiums this year. HHS is now doing a correction and reducing premiums by 3%. But the standard monthly Medicare premium next year will still be $16 higher than in 2021.
The Democratic Medicare price controls will result in fewer innovative treatments. Biogen on Tuesday announced promising trial results for another Alzheimer’s drug. Let’s hope the Biden Administration doesn’t ration that too.
But his Administration this spring restricted access to the drug because of its high price (originally $56,000) and messy trial data. Only patients who enroll in a randomized controlled trial can receive the drug, the first time the government has limited Medicare drug coverage in this way.
The White House reports there will be no press conference tomorrow.
In Related News:
ABC News with the Washington Post released a new poll, which found only 35% prefer President Biden over a new candidate and that 56% want someone else.
From The Daily Wire, “The low polling in support of Biden running again in 2024 could also have a negative impact on the November midterm elections for Democrats. A variety of polls have shown Republicans leading in key House matchups.”
If you’re willing to fight for Main Street America, click here to sign up for the Richardcyoung.com free weekly email.